AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $435,000 | -35.5% | 1,500,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $674,850 | -14.5% | 1,500,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $789,000 | +4.1% | 1,500,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $758,000 | -84.0% | 1,500,000 | +50.0% | 0.00% | -77.8% |
| Q4 2021 | $4,750,000 | -82.9% | 1,000,000 | -71.4% | 0.01% | -83.6% |
| Q3 2021 | $27,825,000 | +31.1% | 3,500,000 | +14.8% | 0.06% | +31.0% |
| Q2 2021 | $21,225,000 | -9.1% | 3,049,581 | +3.4% | 0.04% | -12.5% |
| Q1 2021 | $23,349,000 | -0.8% | 2,948,141 | -1.5% | 0.05% | -5.9% |
| Q4 2020 | $23,547,000 | +11.0% | 2,992,000 | 0.0% | 0.05% | -3.8% |
| Q3 2020 | $21,213,000 | -20.7% | 2,992,000 | +3.5% | 0.05% | -22.1% |
| Q2 2020 | $26,751,000 | +290.9% | 2,892,000 | +96.9% | 0.07% | +240.0% |
| Q1 2020 | $6,844,000 | -39.0% | 1,468,591 | 0.0% | 0.02% | -28.6% |
| Q4 2019 | $11,220,000 | -0.6% | 1,468,591 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $11,293,000 | +12.3% | 1,468,591 | 0.0% | 0.03% | +12.0% |
| Q2 2019 | $10,060,000 | -14.9% | 1,468,591 | 0.0% | 0.02% | -16.7% |
| Q1 2019 | $11,822,000 | +8.2% | 1,468,591 | +0.7% | 0.03% | 0.0% |
| Q4 2018 | $10,925,000 | +24.7% | 1,458,591 | +59.3% | 0.03% | +50.0% |
| Q3 2018 | $8,763,000 | -7.0% | 915,702 | +2.8% | 0.02% | -9.1% |
| Q2 2018 | $9,424,000 | +280.0% | 890,702 | +256.3% | 0.02% | +266.7% |
| Q1 2018 | $2,480,000 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |